- #1
Grinkle
Gold Member
- 805
- 230
- TL;DR Summary
- How much risk is one taking if one is a phase 3 participant?
Russia's vaccine news has me pondering.
How often after a successful phase 2 study do phase 3 studies show that the vaccine causes harm?
If I were offered a COVID-19 vaccine that had passed phase 2 trials, I'd accept it. Is that foolhardy of me?
Is it possible to use existing data to model the expected deaths of waiting for phase 3 completion vs skipping phase 3? I am thinking there is risk of ineffectiveness and over-confidence causing more infection, risk of overt harm from the vaccine on the one hand. On the other hand there are the deaths that will occur that wouldn't if the vaccine is effective and introduced early.
How often after a successful phase 2 study do phase 3 studies show that the vaccine causes harm?
If I were offered a COVID-19 vaccine that had passed phase 2 trials, I'd accept it. Is that foolhardy of me?
Is it possible to use existing data to model the expected deaths of waiting for phase 3 completion vs skipping phase 3? I am thinking there is risk of ineffectiveness and over-confidence causing more infection, risk of overt harm from the vaccine on the one hand. On the other hand there are the deaths that will occur that wouldn't if the vaccine is effective and introduced early.